STOCK TITAN

TD SYNNEX CORPORATION SEC Filings

SNX NYSE

Welcome to our dedicated page for TD SYNNEX CORPORATION SEC filings (Ticker: SNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to U.S. Securities and Exchange Commission (SEC) filings for TD SYNNEX Corporation (NYSE: SNX), a global distributor and solutions aggregator for the IT ecosystem. Through these filings, investors can review the company’s official disclosures on financial performance, capital structure, governance and material events.

TD SYNNEX uses current reports on Form 8-K to announce items such as quarterly financial results, dividend declarations, executive leadership changes and financing activities. For example, recent 8-K filings describe fiscal quarter earnings releases furnished under Item 2.02, the declaration of cash dividends on common stock, and the issuance of senior notes due 2029 and 2035, including key terms and intended uses of proceeds.

Alongside 8-Ks, investors can consult annual reports on Form 10-K and quarterly reports on Form 10-Q (where available in the feed) for more detailed discussions of TD SYNNEX’s business, risk factors, segment information and financial statements. These core filings are complemented by other documents such as registration statements and prospectus supplements referenced in connection with debt offerings.

On Stock Titan, TD SYNNEX filings are updated in near real time from the SEC’s EDGAR system. AI-powered tools help summarize lengthy documents, highlight key sections and clarify non-GAAP metrics the company uses, such as non-GAAP gross billings, non-GAAP operating income, non-GAAP net income, non-GAAP diluted EPS, Adjusted EBITDA, free cash flow and adjusted return on invested capital. Users can also review disclosures related to executive appointments, compensation arrangements and other governance matters reported under Item 5.02 of Form 8-K.

Together, these filings offer a structured view of how TD SYNNEX reports its financial condition, capital markets activity and corporate developments to regulators and investors.

Rhea-AI Summary

TD SYNNEX insider Dennis Polk reported multiple stock option exercises and related share sales. On January 12, 2026, Polk exercised stock options to acquire 3,997 common shares at $106.35 per share and employee stock options to acquire 15,372 and 631 common shares at $107.32 per share. The options vest 20% after one year from grant and then monthly in 1/60th increments.

On the same date, he sold blocks of common stock, including 7,432 shares at a weighted average price of $149.61, 631 shares at $149.67, and 11,937 shares at a weighted average price of $150.23, with detailed price breakdowns available on request. After these transactions, Polk directly held 34,099 TD SYNNEX common shares and indirectly held 72,807 shares through a trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TD SYNNEX Chief Legal Officer David R. Vetter reported routine equity transactions in company common stock. On January 5, 2026, he acquired 2,908 shares of TD SYNNEX common stock at $0 per share, reflecting the vesting of previously granted restricted stock units that were awarded on January 3, 2023 and tied to performance metrics measured over a three-year period ended November 30, 2025.

On the same date, a separate transaction coded “F” disposed of 763 shares at $153.14 per share. Following these transactions, Vetter directly beneficially owned 71,585 shares of TD SYNNEX common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TD SYNNEX Chief Executive Officer Patrick Zammit reported equity compensation activity. On January 5, 2026, he acquired 4,299 shares of TD SYNNEX common stock at a price of $0.00 per share, representing shares issued upon vesting of restricted stock units awarded on January 3, 2023 and subject to performance metrics measured over a three-year period ended November 30, 2025.

On the same date, he disposed of 1,763 shares of common stock at $153.14 per share. After these transactions, Zammit directly owned 184,828 shares of TD SYNNEX common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

A shareholder of SNX has filed a Rule 144 notice to sell 20,000 shares of common stock on the NYSE through Morgan Stanley Smith Barney LLC. The planned sale, dated around 01/12/2026, has an indicated aggregate market value of $2,999,579.43, compared with 81,437,855 shares of common stock outstanding. The shares to be sold were acquired on 01/12/2026 via a stock option exercise from the issuer for cash.

Over the past three months, the POLK FAMILY TRUST U/T/A DTD 04/25/2007 has reported additional sales of SNX common stock: 3,000 shares on 11/04/2025 for $451,698.18, 3,000 shares on 12/04/2025 for $465,086.50, and 2,853 shares on 01/05/2026 for $438,754.28. The signer represents that they are not aware of undisclosed material adverse information about the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

TD SYNNEX Corporation reported that it has released its financial results for the fiscal fourth quarter ended November 30, 2025. The company also announced a cash dividend of $0.48 per common share to be paid in the first quarter of its 2026 fiscal year. The details of the quarter’s performance and the dividend timing are provided in an accompanying press release.

The company furnished this information via a press release attached as an exhibit, rather than including full financial statements in this report.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.25%
Tags
current report
-
Rhea-AI Summary

TD SYNNEX CORP director reports planned stock sales on Form 4. On 01/05/2026, the reporting person, a director of TD SYNNEX, sold a total of 5,000 shares of common stock in multiple transactions. The sales were coded as open-market sales and were made under a Rule 10b5-1 trading plan that was adopted on July 14, 2025.

The shares were sold at weighted average prices ranging from about $152.81 to $156.42 across several price intervals, as detailed in the footnotes. After these transactions, the director reported owning 47,515 shares of TD SYNNEX common stock directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

TD SYNNEX Corp insider reports planned stock sales by family trust. A director and Hyve Solutions executive of TD SYNNEX Corp filed a Form 4 disclosing multiple open-market sales of common stock on January 5, 2026. The trades were executed under a pre-arranged Rule 10b5-1 trading plan adopted on October 13, 2024 on behalf of the Polk family trust, where the insider is a trustee. The reported sales were made at weighted average prices in ranges such as $152.43–$152.94, $153.05–$153.96, $154.06–$154.80, and $155.19–$155.86, plus one sale at $156.79. Following these transactions, the trust held 72,807 shares indirectly, and the insider also held 34,099 shares directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TD SYNNEX Corp reported an insider transaction by a director involving a small sale of common stock. On 12/04/2025, the director sold 168 shares of TD SYNNEX common stock at a price of $153.38 per share, coded as an open-market sale. After this transaction, the director beneficially owns 7,162 shares, held directly. The filing notes that these sales were carried out under a Rule 10b5-1 trading plan adopted on August 2, 2025, which is a pre-arranged plan designed to allow insiders to trade shares according to preset instructions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TD SYNNEX reported insider stock sales by a director and Hyve Solutions executive. On 12/04/2025, a total of 3,000 shares of common stock were sold in several transactions by a family trust, all coded as open-market sales. The shares were sold at weighted average prices of $154.47, $155.72, and $156.01, with underlying trade prices ranging from $154.17 to $155.91.

The filing notes these transactions were made under a Rule 10b5-1 trading plan adopted on October 13, 2024 for the Polk family trust, of which the insider is a trustee. After these sales, the trust indirectly holds 75,660 shares, and the insider directly holds an additional 34,099 shares of TD SYNNEX common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

TD SYNNEX (SNX) has a notice of proposed insider sale under Rule 144 for 5,853 shares of common stock to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $901,420.53. These shares were acquired as restricted stock units from the issuer on 01/24/2023, with the same date listed as the payment date.

The filing also lists recent sales of TD SYNNEX common stock over the past three months for the same account group: 3,000 shares sold on 11/04/2025 for gross proceeds of $451,697.45, 17,500 shares sold on 10/09/2025 for $2,738,783.60, and 3,000 shares sold on 10/06/2025 for $477,258.30. The issuer reports 81,437,855 shares of common stock outstanding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

What is the current stock price of TD SYNNEX CORPORATION (SNX)?

The current stock price of TD SYNNEX CORPORATION (SNX) is $150 as of January 16, 2026.

What is the market cap of TD SYNNEX CORPORATION (SNX)?

The market cap of TD SYNNEX CORPORATION (SNX) is approximately 12.0B.
TD SYNNEX CORPORATION

NYSE:SNX

SNX Rankings

SNX Stock Data

12.05B
75.98M
6.54%
93.53%
3.14%
Electronics & Computer Distribution
Wholesale-computers & Peripheral Equipment & Software
Link
United States
FREMONT

SNX RSS Feed